An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of two fixed dose
(1200mg/day, 1600mg/day) of INM-176 (a drug of treating dementia) comparing with donepezil
for treatment for patients with Alzheimer type dementia.